LEMAITRE VASCULAR INC 8-K

What Happened LeMaitre Vascular, Inc. held its 2026 Annual Meeting of Stockholders on June 2, 2026 and filed an 8-K reporting the voting outcomes. As of the April 6, 2026 record date, 22,847,798 shares were entitled to vote and 21,336,301 shares were present or represented by proxy at the meeting. Two Class II directors were elected, the advisory vote on executive compensation was approved, and Grant Thornton LLP was ratified as the company’s independent registered public accounting firm for 2026.

Key Details

• Record date and attendance: 22,847,798 shares entitled to vote; 21,336,301 shares present or by proxy.
• Director elections (three-year terms expiring 2029):
  • David B. Roberts: 18,888,412 for; 1,250,012 withheld; 1,197,877 broker non-votes.
  • John A. Roush: 14,229,071 for; 5,909,353 withheld; 1,197,877 broker non-votes.
• Advisory vote on executive compensation: 19,311,813 for; 813,052 against; 13,559 abstain; 1,197,877 broker non-votes.
• Ratification of auditor: Grant Thornton LLP ratified with 21,220,412 for; 108,474 against; 7,415 abstain.

Why It Matters These results confirm board continuity (two Class II directors elected) and strong shareholder approval of the company’s executive compensation on an advisory basis. Ratifying Grant Thornton LLP maintains audit continuity for 2026. The reported broker non-votes and the relatively higher withheld votes for one director are factual voting details investors may watch in future governance disclosures.